301130 西點藥業
按盤價 
30.850 +5.140 (+19.992%)
30.850 +5.140 (+19.992%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.028 | 2.420 | 4.264 | 5.238 | 5.543 |
| 總資產報酬率 ROA (%) | 0.871 | 2.062 | 3.782 | 4.846 | 5.054 |
| 投入資產回報率 ROIC (%) | 0.992 | 2.371 | 4.210 | 5.203 | 5.506 | 邊際利潤分析 |
| 銷售毛利率 (%) | 72.926 | 76.264 | 76.525 | 80.265 | 81.632 |
| 營業利潤率 (%) | 17.507 | 8.610 | 18.071 | 24.680 | 20.405 |
| 息稅前利潤/營業總收入 (%) | 17.964 | 8.949 | 17.185 | 23.424 | 17.472 |
| 淨利潤/營業總收入 (%) | 15.383 | 8.473 | 15.705 | 22.397 | 15.941 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 77.731 | 58.822 | 79.545 | 50.441 | 84.047 |
| 價值變動淨收益/利潤總額(%) | 1.805 | 18.740 | 10.747 | 18.728 | 13.299 |
| 營業外收支淨額/利潤總額(%) | 1.733 | 3.693 | 0.387 | 4.564 | -3.366 | 償債能力分析 |
| 流動比率 (X) | 4.726 | 3.878 | 4.714 | 11.802 | 18.179 |
| 速動比率 (X) | 4.273 | 3.559 | 4.360 | 11.293 | 17.644 |
| 資產負債率 (%) | 12.904 | 11.944 | 11.426 | 7.902 | 7.051 |
| 帶息債務/全部投入資本 (%) | 0.897 | -2.053 | -2.654 | -2.422 | -2.773 |
| 股東權益/帶息債務 (%) | 10,598.581 | -4,769.071 | -3,695.033 | -4,100.446 | -3,581.472 |
| 股東權益/負債合計 (%) | 652.796 | 713.155 | 746.013 | 1,165.461 | 1,318.141 |
| 利息保障倍數 (X) | 121.051 | 1,134.100 | -17.978 | -9.613 | -7.700 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.149 | 53.390 | 45.645 | 51.153 | 51.343 |
| 存貨周轉天數 (天) | 177.954 | 181.354 | 165.475 | 194.413 | 181.359 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
